ESMO: Chi-Med’s surufatinib gears up to challenge Novartis, Pfizer with placebo-topping phase 3

ESMO: Chi-Med’s surufatinib gears up to challenge Novartis, Pfizer with placebo-topping phase 3
ntaylor
Fri, 09/18/2020 – 11:24

Published on Fri, 18 Sep 2020 15:24:52 +0000 with keywords power automate euros to pounds